BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11276355)

  • 1. In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients.
    Borbolla JR; Nájera A; Arana RM; López-Hernández MA; Mendoza Y; Trueba E
    J Hematother Stem Cell Res; 2001 Feb; 10(1):19-21. PubMed ID: 11276355
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
    Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
    J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotransplantation for chronic myeloid leukemia: is it useful?
    Olavarria E
    Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous transplantation of peripheral stem cells in patients with chronic myeloid leukemia after mobilization with high-dose hydroxyurea].
    Ojeda Gutiérrez E; Arrieta Gallastegui R; Bustos JG; Pérez Piño T; Rocha R; Sánchez Godoy P; Lozano M; Bello López JL; Hernández Navarro F
    Sangre (Barc); 1997 Apr; 42 Suppl 1():21-3. PubMed ID: 9381295
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
    Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
    Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
    Alonso K; Medenica R; Morehead G
    Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
    Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
    Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 11. Purging efficacy of ZnPcH₁-based photodynamic therapy on chronic myeloid leukemia bone marrow.
    Huang H; Chen Y; Chen W; Wu Y
    Int J Lab Hematol; 2011 Oct; 33(5):477-82. PubMed ID: 21457188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Carlo-Stella C; Mangoni L; Piovani G; Almici C; Garau D; Caramatti C; Rizzoli V
    Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autologous bone marrow transplantation for CML].
    Nagamura F; Nagamura-Inoue T
    Nihon Rinsho; 2001 Dec; 59(12):2369-74. PubMed ID: 11766341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to hematopoietic stem-cell purging in chronic myeloid leukemia.
    O'Brien SG; Goldman JM
    J Clin Oncol; 1995 Mar; 13(3):541-6. PubMed ID: 7884413
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous bone marrow transplantation in chronic myeloid leukaemia.
    Divya
    Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous blood stem-cell transplantation and recombinant interferon alfa in chronic myeloid leukemia.
    Reiffers J; Montastruc M; Cahn JY; Souillet G; Troncy J; Leblond V; Caillot D; Troussard X; Marit G; Fabères C
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):51-2. PubMed ID: 8235709
    [No Abstract]   [Full Text] [Related]  

  • 19. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A
    Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.